HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mydriasis and glaucoma: exploding the myth. A systematic review.

AbstractAIMS:
To investigate the risk of inducing acute glaucoma following mydriasis.
METHODS:
Systematic review of published research 1933-1999.
RESULTS:
The risk of inducing acute glaucoma following mydriasis with tropicamide alone is close to zero, no case being identified. The risk with long-acting or combined agents is between 1 in 3,380 and 1 in 20,000. The presence of chronic glaucoma constitutes no additional risk.
CONCLUSIONS:
Mydriasis with tropicamide alone is safe even in people with chronic glaucoma. It should be advised in all patients when thorough retinal examination is indicated.
AuthorsR J Pandit, R Taylor
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 17 Issue 10 Pg. 693-9 (Oct 2000) ISSN: 0742-3071 [Print] England
PMID11110501 (Publication Type: Journal Article, Review, Systematic Review)
Chemical References
  • Mydriatics
  • Tropicamide
Topics
  • Glaucoma (etiology)
  • Humans
  • Mydriasis (complications)
  • Mydriatics (adverse effects)
  • Risk Factors
  • Safety
  • Tropicamide (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: